carbonyl cyanide p-trifluoromethoxyphenylhydrazone has been researched along with Leukemia in 1 studies
Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone: A proton ionophore that is commonly used as an uncoupling agent in biochemical studies.
carbonyl cyanide p-trifluoromethoxyphenylhydrazone : A hydrazone that is hydrazonomalononitrile in which one of the hydrazine hydrogens is substituted by a p-trifluoromethoxyphenyl group.
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X | 1 |
| Khdour, OM | 1 |
| Jaruvangsanti, J | 1 |
| Hecht, SM | 1 |
1 other study available for carbonyl cyanide p-trifluoromethoxyphenylhydrazone and Leukemia
| Article | Year |
|---|---|
Simplified bicyclic pyridinol analogues protect mitochondrial function.
Topics: alpha-Tocopherol; Antioxidants; Cell Line, Tumor; Drug Design; Drug Evaluation, Preclinical; Humans; | 2012 |